Site icon YCNews

The core indicators of the epidemic in the United States remain high, and vaccinators have allergic reactions.

The core indicators of the epidemic in the United States remain high, and vaccinators have allergic reactions.

On December 5th, local time, a man was vaccinated against the novel coronavirus in Moscow, Russia. As the coronavirus epidemic continues to spread in Russia, the Russian capital Moscow began mass vaccination on the 5th.

Washington, December 17 Summary: The core indicators of the epidemic in the United States remain high, and vaccinators have allergic reactions.

According to the latest epidemic data released by the Centers for Disease Control and Prevention on the 17th, more than 230,000 new confirmed cases of the novel coronavirus were reported in the United States on the 16th, reaching 236,913 cases and 3,435 new deaths. The core indicators are still hovering at a high level.

According to the latest statistics of the epidemic situation of Johns Hopkins University in the United States, as of the evening of the 17th Eastern Time, the cumulative number of confirmed cases in the United States has exceeded 17 million, reaching nearly 17.2 million, and the cumulative number of deaths has exceeded 310,000. It took just five days for the number of confirmed cases of COVID-19 in the United States to increase from 16 million to 17 million.

According to the data of the American epidemic tracking project launched by Atlantic Monthly, as of the 16th, more than 114,000 people were hospitalized for the novel coronavirus in the United States, the highest number since the outbreak.

This week, the United States launched the coronavirus vaccination. The first vaccine approved for emergency use in the United States is a joint COVID-19 vaccine developed by Pfizer Pharmaceutical Co., Ltd. and German biotechnology company. Vaccines were distributed to the states one after another, and the first groups of vaccination were medical staff and groups living in long-term care institutions such as nursing homes.

According to a U.S. media report on the 17th, two hospital staff in Alaska developed allergic reactions after being vaccinated against the above-mentioned coronavirus vaccine, one of whom was hospitalized for observation.

CNN reported that a hospital worker blushed after 10 minutes of vaccination, and then suffered from shortness of breath and elevated heart rate. He was hospitalized for two nights.

Another staff member suffered from eye edema, dizziness and throat after 10 minutes of vaccination, and recovered an hour later. Normal. This is the first and second case of vaccine allergy that has been widely reported in the U.S. media since vaccination began in the United States.

While vaccination is advancing, the number of confirmed cases, deaths and hospitalizations reported throughout the United States continues to surge, and the medical systems in many places are facing unprecedented pressure.

According to the data of the Tracking the National Epidemic Project, California has more than 250,000 new confirmed cases in the past week, and Los Angeles County, with a population of about 10 million, is now infected with the novel coronavirus in 1 in 80 people.

Project data also shows that long-term care institutions such as nursing homes in the United States have recently been the “hardest hit areas” of the epidemic. Over the past week, state long-term care facilities have reported more than 61,000 confirmed cases and more than 5,000 deaths, which is the highest since the project began collecting relevant data at the end of May.

The project said that the coronavirus vaccine may soon reach these high-risk groups. The vaccine is expected to prevent future outbreaks of COVID-19, but for many groups and staff living in long-term care facilities, the vaccine came too late.”

U.S. public health experts stressed that vaccines are not a substitute for epidemic prevention measures, and call on the public to continue to effectively implement public health measures, including wearing masks, social distancing, avoiding gatherings, especially indoor gatherings, to prevent the epidemic from worsening further.

Exit mobile version